Regulatory T cells in atopic dermatitis

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 4, Issue 3, 2010, Pages 244-248

  Oiso, Naoki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Regulatory T cells

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BAMBOO EXTRACT; BETAMETHASONE DIPROPIONATE; CLEMASTINE FUMARATE; CORTICOSTEROID; EMOLLIENT AGENT; FILAGGRIN; HAPTEN; HERBACEOUS AGENT; SCUTELLARIA EXTRACT; TRANSCRIPTION FACTOR FOXP3; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; ATOPIC DERMATITIS; CD4+ CD25+ T LYMPHOCYTE; CHINESE MEDICINE; DENDRITIC CELL; EFFECTOR CELL; GENE EXPRESSION; HERBAL MEDICINE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IPEX SYNDROME; NONHUMAN; PATCH TEST; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN BIOPSY; SKIN MANIFESTATION; SKIN PENETRATION; SKIN SENSITIZATION; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 78649370568     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221310793564227     Document Type: Article

References (53)

1. Neame RL, Berth-Jones J, Kurinczuk JJ, Graham-Brown RA. Prevalence of atopic dermatitis in Leicester: A study of methodology and examination of possible ethnic variation. Br J Dermatol 1995; 132: 772-7.
2. Saeki H, Iizuka H, Mori Y, Akasaka T, Takagi H, Kitajima Y, et al. Community validation of the UK diagnostic criteria for atopic dermatitis in Japanese elementary schoolchildren. J Dermatol Sci 2007; 47: 227-31.
3. Saeki H, Oiso N, Honma M, Iizuka H, Kawada A, Tamaki K. Prevalence of atopic dermatitis in Japanese adults and community validation of the U.K. diagnostic criteria. J Dermatol Sci 2009; 55: 140-1.
4. Saeki H, Oiso N, Honma M, Odajima H, Iizuka H, Kawada A, et al. Comparison of prevalence of atopic dermatitis in Japanese elementary schoolchildren between 2001/2002 and 2007/2008. J Dermatol 2009; 36: 512-4.
5. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
6. Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003; 148: 665-9.
7. Oiso N, Fukai K, Ishii M. Interleukin 4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan. Br J Dermatol 2000; 142: 1003-6.
8. Hosomi N, Fukai K, Oiso N, Kato A, Ishii M, Kunimoto H, et al. Polymorphisms in the promoter of the interleukin-4 receptor alpha chain gene are associated with atopic dermatitis in Japan. J Invest Dermatol 2004; 122: 843-5.
9. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linled neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18-20.
10. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-1.
11. Kisich KO, Carspecken CW, Fiéve S, Boguniewicz M, Leung DY. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 2008; 122: 62-8.
12. Takahata Y, Sugita T, Kato H, Nishikawa A, Hiruma M, Muto M. Cutaneous Malassezia flora in atopic dermatitis differs between adults and children. Br J Dermatol 2007; 157: 1178-82.
13. van Amelsfort JM, van Roon JA, Noordegraaf M, Jacobs KM, Bijlsma JW, Lafeber FP, et al. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007; 56: 732-42.
14. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-87.
15. Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116: 961-8.
16. Zhou Z, Song X, Li B, Greene MI. FOXP3 and its partners: Structural and biochemical insights into the regulation of FOXP3 activity. Immunol Res 2008; 42: 19-28.
17. Riedler J, Braun-Fahrländer C, Eder W, Schreuer M, Waser M, Maisch S, et al. Exposure to farming in early life and development of asthma and allergy: A cross-sectional survey. Lancet 2001; 358: 1129-33.
18. Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347: 869-77.
19. Simon D, Braathen LR, Simon HU. Increased lipopolysaccharide-induced tumour necrosis factor-alpha, interferon-gamma and interleukin-10 production in atopic dermatitis. Br J Dermatol 2007; 157: 583-6.
20. Brown SJ, McLean WH. Eczema genetics: Current state of knowledge and future goals. J Invest Dermatol 2009; 129: 543-52.
21. Weidinger S, Rummler L, Klopp N, Wagenpfeil S, Baurecht HJ, Fischer G, et al. Association study of mast cell chymase polymorphisms with atopy. Allergy 2005; 60: 1256-61.
22. Fallon PG, Sasaki T, Sandilands A, Campbell LE, Saunders SP, Mangan NE, et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009; 41: 602-8.
23. Moniaga CS, Egawa G, Kawasaki H, Hara-Chikuma M, Honda T, Tanizaki H, et al. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermato- phagoides pteronyssinus extract. Am J Pathol 2010; 176: 2385-93.
24. Halabi-Tawil M, Ruemmele FM, Fraitag S, Rieux-Laucat F, Neven B, Brousse N, et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 2009; 160: 645-51.
25. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrino- pathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39: 537-45.
26. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy and fatal infection in infancy. J Pediatr 1982; 100: 731-7.
27. Owen CJ, Jennings CE, Imrie H, Lachaux A, Bridges NA, Cheetham TD, et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation polyendocrinopathy, enteropathy syndrome. J Clin Edocrinol Metab 2003; 88: 6034-9.
28. Ruemmele FM, Brousse N, Goulet O. Autoimmune enteropathy: Molecular concepts. Curr Opin Gastroenterol 2004; 20: 587-91.
29. Baud O, Goulet O, Canioni D, Radford I, Rieu D, Dupuis-Girod S, et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogenic bone marrow transplantation. N Engl J Med 2001; 344: 1758-62.
30. Rao A, Kamani N, Filipovich A, Lee S M, Davies SM, Dalal J, et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 2007; 109: 383-5.
31. Nieves DS, Phipps RP, Pollock SJ, Ochs HD, Zhu Q, Scott GA, et al. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 2004; 140: 466-72.
32. De Benedetti F, Insalaco A, Diamanti A, Cortis E, Muratori F, Lamioni A, et al. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clin Gastroenterol Hepatol 2006; 4: 653-9.
33. Szegedi A, Baráth S, Nagy G, Szodoray P, Gál M, Sipka S, et al. Regulatory T cells in atopic dermatitis: Epidermal dendritic cell clusters may contribute to their local expansion. Br J Dermatol 2009; 160: 984-93.
34. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
35. Sletten GB, Halvorsen R, Egaas E, Halstensen TS. Memory T cell proliferation in cow's milk allergy after CD25+ regulatory T cell removal suggests a role for casein-specific cellular immunity in IgE-mediated but not in non-IgE-mediated cow's milk allergy. Int Arch Allergy Immunol 2007; 142: 190-8.
36. Darsow U, Vieluf D, Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: A randomized, double-blind multicenter study. Atopy patch test study group. J Am Acad Dermatol 1999; 40: 187-93.
37. Caproni M, Antiga E, Torchia D, Volpi W, Barletta E, Gitti G, et al. FoxP3-expressing T regulatory cells in atopic dermatitis lesions. Allergy Asthma Proc 2007; 28: 525-8.
38. Schnopp C, Rad R, Weidinger A, Weidinger S, Ring J, Eberlein B, et al. Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy. Photodermatol Photoimmunol Photomed 2007; 23: 81-5.
39. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006; 117: 176-83.
40. Ito Y, Adachi Y, Makino T, Higashiyama H, Fuchizawa T, Shimizu T, et al. Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis. Ann Allergy Asthma Immunol 2009; 103: 160-5.
41. Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004; 113: 756-63.
42. Vukmanovic-Stejic M, McQuaid A, Birch KE, Reed JR, Macgregor C, Rustin MH, et al. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. Br J Dermatol 2005; 153: 750-7.
43. Maggi L, Santarlasci V, Liotta F, Frosali F, Angeli R, Cosmi L, et al. Demonstration of circulating allergen-specific CD4+ CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007; 120: 429-36.
44. McFadden JP, White JM, Basketter DA, Kimber I. Reduced allergy rates in atopic eczema to contact allergens used in both skin products and foods: Atopy and the 'hapten-atopy hypothesis'. Contact Dermatitis 2008; 58: 156-8.
45. McFadden JP, White JM, Basketter DA, Kimber I. Dose hapten exposure predispose to atopic disease? The haptenatopy hypothesis. Trends Immunol 2009; 30: 67-74.
46. Ozdemir C, Akdis M, Akdis CA. T regulatory cells and their counterparts: Masters of immune regulation. Clin Exp Allergy 2009; 39: 626-39.
47. Kikuchi K, Tagami H. Japanese Cosmetic Scientist Task Force for Skin Care of Atopic Dermatitis. Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons. Br J Dermatol 2008; 158: 969-78.
48. Oiso N, Yudate T, Kawara S, Kawada A. Successful treatment of lichen amyloidosus associated with atopic dermatitis using a combination of narrowband ultraviolet B phototherapy, topical corticosteroids and an antihistamine. Clin Exp Dermatol 2009; 34: e833-6.
49. Dugger, H. Antihistamine/corticosteroid preparations for the treatment of atopic dermatitis WO2009070431 (2009).
50. Yi, C., Tugen, Y., Jintu, Z., Maocan, T., Yaokang, C. Z. Traditional Chinese medicine extract for treating atopic dermatitis and granules thereof. CN101491575 (2009).
51. Young, C.L., Sung, S.W., Dong, S.K., Eun, J.S. Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria. US2010015257 (2010).
52. Leung TF, Wong KY, Wong CK, Fung KP, Lam CW, Fok TF, et al. In vitro and clinical immunomodulatory effects of a novel Pentaherbs concoction for atopic dermatitis. Br J Dermatol 2008; 158: 1216-23.
53. Hon KL, Leung TF, Ng PC, Lam MC, Kam WY, Wong KY, et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: A randomized, double-blind, placebo-controlled study. Br J Dermatol 2007; 157: 357-63.